A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

Clinical Trial ID NCT01378871

PubWeight™ 1.16^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01378871

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.	N Engl J Med	1995	3.26
2	Natural history of adult T-cell leukemia/lymphoma and approaches to therapy.	Oncogene	2005	1.65
3	Immunotoxins for leukemia.	Blood	2014	1.33
4	Immunotoxins: an update.	Annu Rev Immunol	1996	1.22
5	The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.	Blood	1993	1.22
6	Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2.	Blood	1988	1.18
7	Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.	Biol Blood Marrow Transplant	2004	1.09
8	A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.	Blood	1997	0.96
9	Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin.	Leukemia	2000	0.90
10	Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation.	Cytotherapy	2005	0.77
11	Large scale preparation of immunotoxins constructed with the Fab' fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain.	J Immunol Methods	1988	0.77
12	Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins.	Blood	1994	0.77
13	Development of immunotoxins for potential clinical use in Hodgkin's disease.	Ann Oncol	1996	0.75